查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888781

美国电疗市场规模、份额和趋势分析报告：按治疗方法、应用和细分市场预测（2025-2033 年）

U.S. Electrotherapy Market Size, Share & Trends Analysis Report By Therapy Type (Transcutaneous Electrical Nerve Stimulation (TENS), NMES/FES), By Application, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国电疗市场摘要

2024年美国电疗市场规模估计为4.8031亿美元，预计2033年将达到6.939亿美元。

预计从 2025 年到 2033 年，该市场将以 4.24% 的复合年增长率成长。这一增长归因于慢性疼痛、肌肉骨骼疾病和运动相关损伤的日益普遍，这些疾病推动了对非侵入性、无药物疼痛管理解决方案的需求。

人口老化加剧，老年人罹患关节炎、神经病变和术后疼痛的风险更高，也进一步推动了市场成长。此外，携带式、穿戴式和智慧电疗设备等技术的进步，以及整合数位监测功能的出现，正在提高治疗效果和患者便利性。人们越来越偏好居家医疗和復健治疗，以及疼痛管理方式向非鸦片类药物的转变，持续推动着美国临床和家庭环境中电疗设备的普及。

美国市场另一个主要成长要素是人口快速老化。老年人更容易患上关节炎、神经病变以及中风后行动不便等疾病。根据美国人口普查局预测，到2035年，美国老年人口（65岁及以上）将首次超过儿童人口，这将显着增加需要长期疼痛管理和肌肉功能管理治疗的患者群体。电疗在老年护理中应用日益广泛，用于改善肌肉功能、血液循环和整体活动能力，从而提高老年人的生活品质。此外，美国持续不断的鸦片类药物危机也促使人们更加关注非鸦片类镇痛方案。联邦政府的倡议，例如美国疾病管制与预防中心（美国）推荐使用非药物疗法治疗慢性疼痛的指南，正在鼓励医生和患者选择电疗这种更安全、无成瘾性的替代疗法。

非侵入性、无药物止痛疗法的日益普及是推动美国电疗设备市场发展的关键因素。随着鸦片类药物危机持续蔓延，医疗服务提供者和患者都在寻求比传统止痛药更安全的替代方案。电疗能够有效缓解局部疼痛，并避免了阿片类药物相关的成瘾风险和全身性副作用。美国疾病管制与预防中心 (CDC) 等联邦政府机构发布的指南，建议使用非药物疗法治疗慢性疼痛，进一步加速了医院、復健中心和居家医疗机构对电疗设备的采用。随着人们对阿片类药物相关风险的认识不断提高，预计对经皮神经电刺激 (TENS) 和神经肌肉电刺激 (NMES) 等电疗设备的需求将显着增长，从而推动美国医疗保健领域向更安全、技术主导的疼痛管理解决方案转变。

人们对復健疗法的日益重视和广泛应用，透过提升术后护理的整体连续性，间接推动了美国电外科市场的发展。随着越来越多的患者和医疗专业人员认识到术后復健在加速復健和改善功能预后的重要性，包括使用电外科设备在内的微创手术技术的需求也在不断增长。电外科技术能够精准地切割、凝血和止血，同时最大限度地减少热伤害。这不仅减少了手术创伤，加速了术后康復，也使患者能够更早开始復健。这些先进的手术技术与以復健为中心的治疗方案相结合，促使医院和手术中心采用最新的电外科系统，以支持更快的癒合、更少的併发症和更高的患者活动能力，最终推动了美国市场的发展。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国电疗市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关及配套市场展望
  • 市场动态
  • 美国电疗市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章：美国电疗市场：治疗方法的估算与趋势分析

  • 依治疗方法分析美国电疗市场的变化
  • 美国电疗市场规模及趋势分析（依治疗方法，2021-2033 年）
  • 经皮电刺激（TENS）
  • 干涉聚焦心灵感应（IFT）
  • NMES/FES
  • 其他的

第五章：美国电疗市场：按应用分類的估算与趋势分析

  • 按应用领域分析美国电疗市场波动
  • 美国电疗市场规模及应用趋势分析（2021-2033）
  • 神经系统疾病
  • 肌肉损伤
  • 发炎
  • 缓解疼痛
  • 其他的

第六章 竞争情势

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商概况
    • Key company market share analysis, 2024
    • Zynex Medical
    • BTL Group of Companies
    • Omron Healthcare, Inc.
    • NeuroMetrix, Inc.
    • GymnaUniphy
    • Enovis Corporation
    • Medtronic
    • Omron Healthcare, Inc.
    • Dentis Co., Ltd.
    • Stymco
    • RS Medical
    • Orthofix Medical
Product Code: GVR-4-68040-807-8

U.S. Electrotherapy Market Summary

The U.S. electrotherapy market size was estimated at USD 480.31 million in 2024 and is anticipated to reach USD 693.90 million by 2033, expanding at a CAGR of 4.24% from 2025 to 2033. This growth is attributed to the growing prevalence of chronic pain, musculoskeletal disorders, and sports-related injuries, which have increased the demand for non-invasive and drug-free pain management solutions.

The aging population, which is more prone to arthritis, neuropathy, and post-surgical pain, further fuels market growth. In addition, advancements in technology, such as portable, wearable, and smart electrotherapy devices integrated with digital monitoring, are enhancing treatment efficacy and patient convenience. The rising preference for home healthcare and rehabilitation therapies, combined with the shift away from opioid-based pain management, continues to strengthen the adoption of electrotherapy devices across clinical and home settings in the U.S.

Another key growth driver in the U.S. market is the rapidly aging population, which is highly susceptible to conditions such as arthritis, neuropathy, and post-stroke mobility limitations. The U.S. Census Bureau projects that by 2035, older adults (aged 65 and above) will outnumber children for the first time in U.S. history, creating a substantial patient base requiring long-term pain and muscle management therapies. Electrotherapy is increasingly being adopted in geriatric care to improve muscle function, circulation, and overall mobility, thereby enhancing quality of life. Moreover, the ongoing opioid crisis in the U.S. has strengthened the focus on non-opioid pain management solutions. Federal initiatives, such as the CDC's guidelines promoting non-pharmacological treatments for chronic pain, have further encouraged physicians and patients to opt for electrotherapy as a safer, non-addictive alternative.

The growing shift toward non-invasive and drug-free pain management therapies is a significant factor driving the U.S. electrotherapy device market. With the nation grappling with an ongoing opioid crisis, both healthcare providers and patients are increasingly seeking safer alternatives to traditional pain medications. Electrotherapy offers effective, localized pain relief without the risk of addiction, dependency, or systemic side effects associated with opioids. Federal initiatives, such as the Centers for Disease Control and Prevention (CDC) guidelines promoting non-pharmacological approaches for chronic pain, have further accelerated the adoption of electrotherapy devices across hospitals, rehabilitation centers, and home care settings. As awareness of opioid-related risks continues to rise, the demand for electrotherapy devices, such as Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) systems, is expected to grow significantly, supporting the broader shift toward safer, technology-driven pain management solutions in the U.S. healthcare landscape.

The growing awareness and adoption of rehabilitation therapies indirectly drive the U.S. electrosurgery market by enhancing the overall continuum of care following surgical procedures. As more patients and clinicians recognize the importance of post-surgical rehabilitation for faster recovery and improved functional outcomes, the demand for minimally invasive surgical techniques, including those performed with electrosurgical devices, is increasing. Electrosurgery enables precise tissue cutting, coagulation, and hemostasis with minimal thermal damage, which helps reduce surgical trauma and accelerates postoperative recovery, allowing patients to begin rehabilitation sooner. This alignment between advanced surgical methods and rehabilitation-focused treatment pathways encourages hospitals and surgical centers to adopt modern electrosurgical systems that support quicker healing, fewer complications, and improved patient mobility, ultimately fueling market growth in the U.S.

U.S. Electrotherapy Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. electrotherapy market report on the basis of therapy type and application:

  • Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Interferential Therapy (IFT)
  • NMES/FES
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Nervous Disease
  • Muscle Injury
  • Inflammation
  • Pain Relief
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Type
    • 1.1.2. Application
    • 1.1.3. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Price Analysis (Model 1)
    • 1.6.2. Approach 1: Commodity Flow Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Electrotherapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic pain and musculoskeletal disorders
      • 3.2.1.2. Increasing geriatric population
      • 3.2.1.3. Growing adoption of non-invasive and drug-free pain management therapies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced electrotherapy devices
      • 3.2.2.2. Limited clinical evidence and skepticism among healthcare professionals
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Integration of AI and IoT in electrotherapy devices
      • 3.2.3.2. Rising demand in home-based rehabilitation and telehealth settings
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Stringent quality and safety standards
  • 3.3. U.S. Electrotherapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Electrotherapy Market: Therapy Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Electrotherapy Market Therapy Type Movement Analysis
  • 4.3. U.S. Electrotherapy Market Size & Trend Analysis, by Therapy Type 2021 to 2033 (USD Million)
  • 4.4. Transcutaneous Electrical Nerve Stimulation (TENS)
    • 4.4.1. Transcutaneous Electrical Nerve Stimulation (TENS) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.5. Interferential Therapy (IFT)
    • 4.5.1. Interferential Therapy (IFT) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.6. NMES/FES
    • 4.6.1. NMES/FES Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 5. U.S. Electrotherapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Electrotherapy Market Application Movement Analysis
  • 5.3. U.S. Electrotherapy Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Nervous Disease
    • 5.4.1. Nervous Disease Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.5. Muscle Injury
    • 5.5.1. Muscle Injury Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.6. Inflammation
    • 5.6.1. Inflammation Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.7. Pain Relief
    • 5.7.1. Pain Relief Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. Key company market share analysis, 2024
    • 6.3.2. Zynex Medical
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Usage benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. BTL Group of Companies
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Usage benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Omron Healthcare, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Usage benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. NeuroMetrix, Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Usage benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. GymnaUniphy
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Usage benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Enovis Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Usage benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Medtronic
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Usage benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Omron Healthcare, Inc.
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Usage benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Dentis Co., Ltd.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Usage benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Stymco
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Usage benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. RS Medical
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Usage benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Orthofix Medical
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Usage benchmarking
      • 6.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. electrotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 4. U.S. electrotherapy market, by therapy type, 2021 - 2033 (USD Million)
  • Table 5. U.S. electrotherapy market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Electrotherapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Electrotherapy Market: Therapy Type Movement Analysis
  • Fig. 14 Transcutaneous Electrical Nerve Stimulation (TENS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Interferential Therapy (IFT) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 NMES/FES Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Dental Implant Market: Application Movement Analysis
  • Fig. 19 Nervous Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Muscle Injury Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Inflammation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Pain Relief Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)